JCR PHARMACEUTICALS CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 807 JPY | +0.12% |
|
-0.98% | -31.14% |
| Apr. 25 | JCR Pharmaceuticals Co., Ltd. Announces Management Changes, Effective as of June 26, 2024 | CI |
| Mar. 21 | US Fed Rate Outlook Catapults Japanese Shares to Fresh 52-Week Peak | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 45.37B 294M | Sales 2025 * | 41.75B 271M | Capitalization | 101B 652M |
|---|---|---|---|---|---|
| Net income 2024 * | 7.24B 46.99M | Net income 2025 * | 6.28B 40.75M | EV / Sales 2024 * | 2.5 x |
| Net Debt 2024 * | 12.66B 82.11M | Net Debt 2025 * | 9B 58.35M | EV / Sales 2025 * | 2.62 x |
| P/E ratio 2024 * |
13.9
x | P/E ratio 2025 * |
16
x | Employees | 879 |
| Yield 2024 * |
2.43% | Yield 2025 * |
2.48% | Free-Float | 52.97% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | +0.12% | ||
| 1 week | -0.98% | ||
| Current month | -0.98% | ||
| 1 month | -0.62% | ||
| 3 months | -19.30% | ||
| 6 months | -34.07% | ||
| Current year | -31.14% |
1 week
796.00
814.00
1 month
773.00841.00
Current year
773.001 228.00
1 year
773.001 567.00
3 years
773.003 745.00
5 years
773.003 800.00
10 years
440.253 800.00
| Managers | Title | Age | Since |
|---|---|---|---|
Shin Ashida
CEO | Chief Executive Officer | 81 | 75-09-12 |
Hiroyuki Sonoda
CTO | Chief Tech/Sci/R&D Officer | 45 | 03-03-31 |
Yutaka Honda
ADM | Chief Administrative Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shin Ashida
CEO | Chief Executive Officer | 81 | 75-09-12 |
Philippe Fauchet
BRD | Director/Board Member | 65 | - |
Toru Ashida
BRD | Director/Board Member | 55 | 13-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.67% | 23 M€ | +3.18% | - | |
| 0.30% | 15 M€ | +10.21% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-06 | 807 | +0.12% | 103 100 |
| 24-05-02 | 806 | -0.86% | 415,200 |
| 24-05-01 | 813 | -0.25% | 355,400 |
Delayed Quote Japan Exchange, May 06, 2024 at 09:13 pm EDT
More quotes
JCR Pharmaceuticals Co., Ltd. is a Japan-based company primarily engaged in the pharmaceutical business, as well as the medical and research equipment business. The Company operates in two segments. The Pharmaceutical segment engages in the research, production, purchase and sale of medical drugs and pharmaceutical raw materials. The Medical and Research Equipment segment engages in the purchase and sale of the medical and research equipment.
Sector
Pharmaceuticals
Calendar
2024-05-09
- Q4 2023 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
806
JPY
Average target price
1,557
JPY
Spread / Average Target
+93.19%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -31.14% | 658M | |
| +31.52% | 662B | |
| +21.96% | 546B | |
| -5.21% | 359B | |
| +17.02% | 323B | |
| +5.01% | 289B | |
| +13.68% | 234B | |
| +3.81% | 198B | |
| -10.63% | 194B | |
| +3.98% | 167B |
- Stock Market
- Equities
- 4552 Stock